作者
柳 叶,仲小敏
文章摘要
在21世纪,肿瘤疾病已成为一个社会、经济、公共卫生的重大问题。据国际癌症研究机构IARC最新数据统计显示,大约有五分之一的男性或女性在一生中会患有癌症[1],癌症以其逐渐增长的发病率、年轻化趋势造成不可估量的“癌症负担”。随着诊疗技术的不断进步,靶向、免疫等治疗方法持续更新,新的靶点、生物标志物层出不穷,在其中筛选出具有潜力和新意的目标是十分必要的。APLN基因参与调节能量代谢、体液平衡、维持血管更新稳态,是在细胞代谢活动中十分活跃的一个基因。研究表明APLN基因及其受体APJ的表达与肿瘤的发生发展关系密切,它在肝细胞癌、非小细胞肺癌、食管癌、胶质母细胞瘤等众多癌种中广泛高表达。本文对APLN基因的发现、生理作用、对于肿瘤的不同方面的促进作用都作了详细论述,简述并展望了其作为潜在靶点在目前部分癌种中的治疗效果,为后续研究APLN基因提供总结与参考。
文章关键词
APLN;APLN受体;血管生成;肿瘤代谢;基因表达调控;血管内皮生长因子
参考文献
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] O'Dowd BF,Heiber M,Chan A,et al.A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.Gene.1993.136(1-2):355-60.
[3] Tatemoto K,Hosoya M,Habata Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.Biochem Biophys Res Commun.1998.251(2):471-6.
[4] Reaux A,De Mota N,Skultetyova I,et al.Physiological role of a novel neuropeptide,apelin,and its receptor in the rat brain.J Neurochem. 2001.77(4):1085-96.
[5] Newson MJ,Pope GR,Roberts EM,Lolait SJ,O'Carroll AM.Stress-dependent and gender-specific neuroregulatory roles of the apelin receptor in the hypothalamic-pituitary-adrenal axis response to acute stress.J Endocrinol.2013.216(1):99-109.
[6] De Mota N,Reaux-Le Goazigo A,El Messari S,et al.Apelin,a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release.Proc Natl Acad Sci U S A.2004.101(28):10464-9.
[7] Tatemoto K,Hosoya M,Habata Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.Biochem Biophys Res Commun.1998.251(2):471-6.
[8] Lee DK,George SR,O'Dowd BF.Unravelling the roles of the apelin system:prospective therapeutic applications in heart failure and obesity.Trends Pharmacol Sci.2006.27(4):190-4.
[9] Reaux A,De Mota N,Skultetyova I,et al.Physiological role of a novel neuropeptide,apelin,and its receptor in the rat brain.J Neurochem. 2001.77(4):1085-96.
[10] Kasai A,Shintani N,Oda M,et al.Apelin is a novel angiogenic factor in retinal endothelial cells.Biochem Biophys Res Commun. 2004.325(2):395-400.
[11] Adhicary S,Fanelli K,Nakisli S,Ward B,Pearce I,Nielsen CM.Rbpj Deficiency Disrupts Vascular Remodeling via Abnormal Apelin and Cdc42(Cell Division Cycle 42)Activity in Brain Arteriovenous Malformation.Stroke.2023.54(6):1593-1605.
[12] Hennigs JK,Cao A,Li CG,et al.PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.Circ Res. 2021.128(3):401-418.
[13] Liu Q,Hu T,He L,et al.Genetic targeting of sprouting angiogenesis using Apln-CreER.Nat Commun.2015.6:6020.
[14] Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation.Cell.2011.144(5):646-74.
[15] CHEN J,GAO G,HE Y,et al.Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis,and therapeutic decision-making[J].Sci Rep,2023,13(1):22624.
[16] CHEN H,WONG C C,LIU D,et al.APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target[J].Theranostics,2019,9(18):5246-5260.
[17] YI Y,TSAI S H,CHENG J C,et al.APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner[J]. Gynecol Oncol,2017,147(3):663-671.
[18] TOLKACH Y,ELLINGER J,KREMER A,et al.Apelin and apelin receptor expression in renal cell carcinoma[J].Br J Cancer, 2019,120(6):633-639.
[19] SORLI S C,LE GONIDEC S,KNIBIEHLER B,et al.Apelin is a potent activator of tumour neoangiogenesis[J]. Oncogene, 2007, 26(55):7692-7699.
[20] CHINOT O L,WICK W,MASON W,et al.Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma[J].N Engl J Med,2014,370(8):709-722.
[21] LU K V,BERGERS G.Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma[J].CNS Oncol,2013,2(1):49-65.
[22] FRISCH A,KÄLIN S,MONK R,et al.Apelin Controls Angiogenesis-Dependent Glioblastoma Growth[J].Int J Mol Sci,2020,21(11)
[23] MASTRELLA G,HOU M,LI M,et al.Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma[J].Cancer Res,2019,79(9):2298-2313.
[24] BERTA J,KENESSEY I,DOBOS J,et al.Apelin expression in human non-small cell lung cancer:role in angiogenesis and prognosis[J].J Thorac Oncol,2010,5(8):1120-1129.
[25] ZHOU Y,XU R,LUO J,et al.Dysregulation of miR-204-5p/APLN axis affects malignant progression and cell stemness of esophageal cancer[J].Mutat Res,2022,825:111791.
[26] KIDOYA H,KUNII N,NAITO H,et al.The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy[J].Oncogene,2012,31(27):3254-3264.
[27] ZHANG L,TAKARA K,YAMAKAWA D,et al.Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy[J].Cancer Sci,2016,107(1):36-44.
Full Text:
DOI